Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov;20(11):3350-3361.
doi: 10.1111/jocd.14521.

Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review

Hardik D Desai  1 , Kamal Sharma  2 , Anchal Shah  3 , Jaimini Patoliya  4 , Anant Patil  5 , Zahra Hooshanginezhad  6 , Stephan Grabbe  7 , Mohamad Goldust  8
Affiliations
Case Reports

Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review

Hardik D Desai et al. J Cosmet Dermatol. 2021 Nov.

Abstract

Introduction: Although the COVID-19 vaccination is deemed safe, exact incidence and nature if adverse effects, particularly dermatological ones, are still unknown.

Objective: To describe the demographic, clinical, morphological characteristics, outcomes, and timing of development of herpes zoster to the various COVID-19 vaccines. And to identify on whether COVID-19 vaccine has temporal relationship between development of herpes zoster (HZ).

Methods: We have performed a systemic review of articles from PubMed and Embase using MeSH and keywords like "Shingles," "Herpes zoster," "Varicella zoster," "COVID-19," "Vaccine," "SARS-CoV-2." No filters including country of publication, language, type of articles were applied. Individual case report references were filtered for any pertinent cases.

Results: A total of 54 cases consisting of 27 male and 27 female patients have been reported. There were cases with known risk factors for herpes zoster, which included age more than 50 years (n = 36), immunological disorders (n = 10), chronic disease (n = 25), metabolic disorder (n = 13), malignancy (n = 4), and psychiatric disorder (n = 2). The mean (SD) period between development of herpes zoster and COVID-19 vaccination was 7.64 (6.92) days. Majority of the cases were from the high-income and/or middle-income countries. 86.27% of the cases of HZ were reported due to mRNA vaccine. Thirty-six patients 36/45 (80%) developed herpes zoster following the priming dose of COVID-19 vaccine among those who received mRNA vaccine.

Conclusion: We could not establish definite link but there may be possible association between COVID-19 vaccine and shingles. Large-scale studies may help to understand the cause-effect relationship.

Keywords: COVID-19; Varicella zoster; herpes zoster; vaccine.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
PRISMA flowchart of study selection
FIGURE 2
FIGURE 2
Period of herpes zoster development following COVID‐19 vaccination (n = 51)
See this image and copyright information in PMC

References

    1. Coronavirus (COVID‐19) Vaccination. Available at https://ourworldindata.org/covid‐vaccinations. Accessed October 1, 2021.
    1. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV‐19 vaccine (AZD1222) against SARS‐CoV‐2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020;397:99‐111. - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid‐19 vaccine. N Engl J Med. 2020;383:1‐13. - PMC - PubMed
    1. McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID‐19 vaccination: a registry‐based study of 414 cases. J Am Acad Dermatol. 2021;85:46‐55. - PMC - PubMed
    1. Johnston MS, Galan A, Watsky KL, Little AJ. Delayed localized hypersensitivity reactions to the moderna COVID‐19 vaccine: a case series. JAMA Dermatol. 2021;157:716‐720. - PMC - PubMed